EVALUATION OF AN IV INSULIN ELECTRONIC GLUCOSE MANAGEMENT SYSTEM USING FDA CLEARED FEATURE OF EREI (ESTIMATED RESIDUAL EXTRACELLULAR INSULIN) TO PREVENT HYPOGLYCEMIA